STAT3/スナイルシグナリングと乳がん細胞における低酸素耐性の進行
Olga E Andreeva1, Danila V Sorokin2, Alexander M Scherbakov2,3
1Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115522, Russia. tilberta@gmail.com.
Biochemistry. Biokhimiia
|August 31, 2025
まとめ
乳がん細胞は,miR-181a-2/STAT3/Snail経路を活性化することで,酸素不足 (低酸素) に適応する. DNAメチル化を阻害することで,この低酸素耐性フェノタイプを逆転させ,新しい治療戦略を提供することができる.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 研究
背景:
- 悪性腫瘍は 低酸素の腫瘍環境で成長を続ける.
- 腫瘍の低酸素は細胞の生存,転移,治療への耐性を促進する.
- 低酸素の適応メカニズムの理解は癌の治療に不可欠です.
研究 の 目的:
- 乳がん細胞が長期にわたる低酸素に適応するメカニズムを調査する.
- 低酸素耐性フェノタイプを維持する重要な分子プレーヤーを特定する.
- 低酸素抵抗性がん細胞を標的とした治療戦略を探る
主な方法:
- 低酸素に適応したMCF-7およびMDA-MB-231の乳がん細胞サブラインが,1%以下の長期培養で確認された.
- STAT3,スナイル,miR-181a-2の表現と標的を分析した.
- DNAメチル化変化とDNMT阻害 (デシタビン) とノックダウンの影響の評価
- 評価されたp53シグナル活性化
主要な成果:
- 低酸素に適応した細胞は低酸素状態でも安定した成長を示した.
- HIF-1α依存のSTAT3活性化とスナイル過剰発現と相関する低酸素耐性.
- miR-181a-2はSTAT3/Snail軸をターゲットとするメディエーターとして特定されました.
- DNMTの阻害/ノックダウンにより,細胞が低酸素に敏感になり,p53信号が活性化されます.
結論:
- 乳がん細胞における得られた低酸素耐性は,部分的にmiR-181a-2/STAT3/Snail経路によって媒介される.
- 脱メチル化剤は低酸素耐性がん群をターゲットにすると有望である.
- エピジェネティック・モディフィケーションをターゲットにすれば,低酸素による治療抵抗を克服できる.
関連する概念動画
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Hedgehog Signaling Pathway
7.5K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.5K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Hypoxia
1.2K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.2K


